APA (7th ed.) Citation

Tegtmeier, F., Schinzel, R., Beer, R., Bulters, D., LeFrant, J., Sahuquillo, J., . . . Schmutzhard, E. (2020). Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): Study protocol of a confirmatory, placebo-controlled, randomised, double blind, multi-centre study. Current controlled trials in cardiovascular medicine, 21(1), 80-9. https://doi.org/10.1186/s13063-019-3965-4

Chicago Style (17th ed.) Citation

Tegtmeier, Frank, et al. "Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA Phase III Trial): Study Protocol of a Confirmatory, Placebo-controlled, Randomised, Double Blind, Multi-centre Study." Current Controlled Trials in Cardiovascular Medicine 21, no. 1 (2020): 80-9. https://doi.org/10.1186/s13063-019-3965-4.

MLA (9th ed.) Citation

Tegtmeier, Frank, et al. "Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA Phase III Trial): Study Protocol of a Confirmatory, Placebo-controlled, Randomised, Double Blind, Multi-centre Study." Current Controlled Trials in Cardiovascular Medicine, vol. 21, no. 1, 2020, pp. 80-9, https://doi.org/10.1186/s13063-019-3965-4.